Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 02, 2016 16:05 ET | Source: Hemostemix Inc.

Hemostemix Closes $1,644,000 Offering

TORONTO, ONTARIO--(Marketwired - Sept. 2, 2016) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM) (OTCQX:HMTXF) today announces it has closed its private placement...
September 01, 2016 08:30 ET | Source: Hemostemix Inc.

Hemostemix Inc. Reminds Shareholders to Vote the WHITE Proxy in Favour of the Current Trusted Board

TORONTO, ONTARIO--(Marketwired - Sept. 1, 2016) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM)(OTCQX:HMTXF) thanks shareholders for their overwhelming support for...
August 29, 2016 17:38 ET | Source: Hemostemix Inc.

Hemostemix Voids Taiwanese Agreement

TORONTO, ONTARIO--(Marketwired - Aug. 29, 2016) - Hemostemix Inc. ("Hemostemix" or the "Company) (TSX VENTURE:HEM) (OTCQX:HMTXF), a clinical-stage autologous cell-therapy company,...
August 29, 2016 08:30 ET | Source: Hemostemix Inc

Hemostemix Issues Letter to Shareholders Urging Them to Vote Their WHITE Proxy

TORONTO, ONTARIO--(Marketwired - Aug. 29, 2016) - Warns shareholders the dissident nominees will put their investment at risk. Encourages...
June 28, 2016 16:01 ET | Source: Hemostemix Inc.

Hemostemix Announces Corporate Updates

TORONTO, ONTARIO--(Marketwired - June 28, 2016) - NOT FOR DISSEMINATION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Hemostemix Inc. ("Hemostemix" or...
May 20, 2016 16:31 ET | Source: Hemostemix Inc.

Hemostemix Announces Resignations

TORONTO, ONTARIO--(Marketwired - May 20, 2016) - NOT FOR DISSEMINATION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Hemostemix Inc. ("Hemostemix" or...
April 20, 2016 16:21 ET | Source: Hemostemix Inc.

Hemostemix Announces Non-Brokered Private Placement

TORONTO, ONTARIO--(Marketwired - April 20, 2016) - NOT FOR DISSEMINATION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Hemostemix Inc. ("Hemostemix" or...
April 18, 2016 08:30 ET | Source: Hemostemix Inc.

Hemostemix Receives IRB Approval from the Houston Methodist Hospital Research Institute and the University of California Los Angeles

TORONTO, ONTARIO--(Marketwired - April 18, 2016) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM)(OTCQX:HMTXF), a clinical-stage autologous cell-therapy company, is...
March 31, 2016 08:30 ET | Source: Hemostemix Inc.

Hemostemix Appoints Robert Achtymichuk as Vice President, Business Development

TORONTO, ONTARIO--(Marketwired - March 31, 2016) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM)(OTCQX:HMTXF), a clinical-stage autologous cell therapy company,...
February 03, 2016 09:36 ET | Source: Hemostemix Inc.

Hemostemix Issues Corporate Update From CEO Elmar Burchardt

TORONTO, ONTARIO--(Marketwired - Feb. 3, 2016) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM)(OTCQX:HMTXF), a clinical-stage autologous cell-therapy company, released...